«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

29卷

期数:

2023年02期

页码:

199-203

栏目:

技术与方法

出版日期:

2023-03-20

文章信息/Info

Title:

Analysis of detection of novel coronavirus-specific antibodies by different methods

文章编号:

1006-8147（2023）02-0199-05

作者:

王倩¹; 2; 张华²; 袁玉华¹

1.天津医科大学总医院检验 科，天津300052;2.天津医科大学总医院空港医院检验 科，天津300300

Author(s):

WANG Qian¹; 2; ZHANG Hua²; YUAN Yu-hua¹

1.Department of Clinical Laboratory，General Hospital，Tianjin Medical University，Tianjin 300052，China;2.Department of Clinical Laboratory，General Hospital Airpot Hospital，Tianjin Medical University，Tianjin 300300，China

关键词:

SARS-CoV-2; COVID-19; 无症状感染者; 胶体金免疫层析法; 磁微粒化学发光法

Keywords:

SARS-CoV-2; COVID-19; asymptomatic infected persons; Colloidal gold immunochromatography; Magnetic particle chemiluminescence method

分类号:

R512.99

DOI:

-

文献标志码:

A

摘要:

目的：比较不同血清学检测方法检测新型冠状病毒特异性抗体的阳性率，比较其在新型冠状病毒肺炎（新冠肺炎）患者和无症状感染者中的差异。方法：使用5种胶体金免疫层析法检测试剂A、B、C、D、E和一种磁微粒化学发光检测试剂F对入院的10例确诊患者和11例无症状感染者血清标本进行检测，其中A试剂检测总抗体，B、C、D、E、F试剂检测抗体IgM，C、D、E、F试剂检测抗体IgG。依据《新型冠状病毒肺炎诊疗方案（试行第九版）》中相关规定以20例已排除新冠病毒感染者为空白对照，计算不同试剂检测抗体IgM和IgG分别在新冠肺炎患者和无症状感染者中的阳性率，通过统计学分析进行比较，实验中所选研究对象均未接种新型冠状病毒肺炎疫苗。结果：总抗体：A试剂阳性检出率为100%，其测定总抗体，不区分抗体IgM和IgG。抗体IgM：10例新冠肺炎患者和11例无症状感染者分别使用B、C、D、E、F方法检测IgM抗体，不同方法学的阳性检出率差异均存在统计学意义（P＜0.05），在新冠肺炎组和无症状感染者组中，胶体金免疫层析法C、D、E检测抗体IgM的阳性检出率均显著低于磁微粒化学发光法F。抗体IgG：新冠肺炎组使用C、D、E、F方法检测IgG抗体的阳性检出率差异不存在统计学意义（P＞0.05），无症状感染组使用C、D、E、F检测IgG抗体的阳性检出率差异存在统计学意义（P＜0.05），胶体金免疫层析法D、E检测抗体IgG的阳性检出率在无症状感染组中低于化学发光法F。结论：磁微粒化学发光法相较于胶体金免疫层析法检测新冠肺炎患者抗体IgM以及无症状感染者抗体IgM和IgG具有更高的阳性检出率，更有利于区分既往感染和当前感染，但其对检测条件

Abstract:

Objective：To compare the positive rates of different serological testing methods for the detection of new coronavirus-specific antibodies，and compare the differences between patients with new coronary pneumonia and those with asymptomatic infection. Methods：Five colloidal gold immunochromatographic detection reagents A，B，C，D，E and a magnetic particle chemiluminescence detection reagent F were used to test the serum samples of 10 confirmed patients and 11 asymptomatic infections in the hospital. Among them，A reagent was used to detect total antibody，B，C，D，E，F reagents were used to detect antibody IgM，C，D，E，F reagents were used to detect antibody IgG. According to the relevant provisions of the "New Coronary Pneumonia Diagnosis and Treatment Plan（Trial Seventh Edition）"，20 cases of patients who have been excluded from new coronavirus infection were used as blank controls，and the positive rate of antibodies IgM and IgG was detected by different reagents in patients with new coronary pneumonia and asymptomatic infections were calculated and compared through statistical analysis.None of the subjects in the study had received the COVID-19 vaccine.Results：Total antibody：the positive detection rate of reagent A was 100%，which measured total antibody without distinguish between antibody IgM and IgG. Antibody IgM：10 patients with new coronary pneumonia and 11 patient with asymptomatic infection used methods B，C，D，E，and F to detect the positive rates of IgM antibodies，and the positive detection rate of different methods were statistically significant（P＜0.05）. In the new coronary pneumonia group and the asymptomatic infection group，the positive rate of the antibody IgM detected by the colloidal gold immunochromatographic method C，D，E was significantly lower than that of the magnetic particle chemiluminescence method F. Antibody IgG：the new coronary pneumonia group used methods C，D，E，and F to detect the positive rate of IgG antibodies，and the difference was not statistically significant（P＞0.05），and the asymptomatic infection group used C，D，E，and F to detect IgG antibodies positive rate，the difference was statistically significant（P＜0.05）. Colloidal gold immunochromatographic methods D and E showed a lower positive test for antibody IgG than chemiluminescence method F in the asymptomatic infection group. Conclusion：Compared with the colloidal gold immunochromatographic method，the magnetic particle chemiluminescence method has a higher positive detection rate for detecting antibodies IgM in patients with new coronary pneumonia and antibodies IgM and IgG in asymptomatic infections. It is more helpful to distinguish past infection from current infection. However，it has higher requirements on detection conditions，and the detection time is relatively long. Colloidal gold immunochromatography has a fast detection speed，but its sensitivity is lower than that of magnetic particle chemiluminescence method.

参考文献/References:

[1] LONG Q X，LIU B Z，DENG H J，et al. Antibody responses to SARS-CoV-2 in patients with COVID-19[J]. NatMed，2020，26（6）：845-848.
[2] 中华人民共和国国家卫生健康委员会.《关于印发新型 冠状病毒肺炎诊疗方 案（试行第七版）的通知》[EB/OL].（2020-03-04）.国卫办医函〔2020〕184 号）.http：//www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml
[3] 中华人民共和国国家卫生健康委员会.《国家卫生健康委办公厅关于印发新型 冠状病毒肺炎防控方 案（第五版）的通知》[EB/OL].（2020-02-21）.（国卫办疾控函〔2020〕156号）.http：//www. gov.cn/zhengce/zhengceku/2020-02/22/content_5482010.htm
[4] JIA XW，ZHANG P J，TIAN Y P，et al. Clinical significance of IgM and IgG test for diagnosis of highly suspected COVID-19 infection[J]. Med Rxiv，[Preprint].March 3.2020.https：//doi.org/10.1101/2020.02. 28.20029025.
[5] The National Center for Disease Control.Interim Guidelines for COVID-19 Antibody Testing.（2020-05-23）. https：//www.cdc.gov/coronavirus/2019 -ncov/lab/resources/antibody -tests -guidelines. html
[6] 中华医学会检验 分会. 2019新型 冠状病毒肺炎临床实 验 室检测的生物安全防护指南（试行第一版）[EB/OL].（2020-01-30）.http：//www.cslm.org.cn/cn/news.asp?id=73.html.
[7] LONG Q，DENG H，CHEN J，et al. Antibody responses to SARS-CoV -2 in COVID -19 patients：the perspective application of serological tests in clinical practice [J]. Med Rxiv，[Preprint]. March20. 2020. https：//doi. org/10.1101//2020.03.18.20038018.
[8] JIANG S ，HILLYER C ，DU L. Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses[J].Trends Immunol， 2020，41（5）：355-359.
[9] ZHANG X M ，WU X，WANG D，et al. Proteome-wide analysis of differentially-expressed SARS-CoV-2 antibodies in early COVID-19 infection [J]. Med Rxiv，[Preprint].April.2020.http：//doi.org/10.1101//2020.04.14.20064535.
[10] SUN Z F，MENG X J. Antigenic cross-reactivity between the nucle－ocapsid protein of severe acute respiratory syndrome（SARS）coron－avirus and polyclonal antisera of antigenic group I animal coron－aviruses：implication for SARS diagnosis[J]. J Clin Microbiol，2004， 42（5）：2351-2352.
[11]中华人民共和国国家卫生健康委员会.《关于印发新型 冠状病毒肺炎诊疗方 案（试行第九版）的通知》[EB/OL].（2022-03-15）.国卫办医函〔2022〕71号）. http：//www.nhc.gov.cn/yzygj/s7653p/202203/b74ade1ba4494583805a3d2e40093

相似文献/References:

备注/Memo

备注/Memo:

基金项目：科技部国家重点研发计划（2020YFC0843100）
作者简介：王倩（1983-），女，主管技师，硕士在读，研究方向：临床检验诊断学新型冠状病毒血清抗体检测，E-mail：wangqian-0201@126.com。

常用功能

更新日期/Last Update: 2023-04-30